U.S. Court of Appeals for the Federal Circuit rejects Allergan's attempt to use tribal sovereign immunity to avoid Restasis® patent challenge
Mylan's IPR challenges to Restasis® patents can proceed
Federal District Court previously held patents invalid
PR Newswire
HERTFORDSHIRE, England and PITTSBURGH, July 20, 2018